RSS Content

Print Page Print Page        E-mail Page Email Page        RSS Feeds RSS        E-mail Alerts Email Alerts        Financial Tear Sheet Tear Sheet
Alkermes to Present at Goldman Sachs 38th Annual Global Healthcare Conference

DUBLIN--(BUSINESS WIRE)--Jun. 8, 2017-- Alkermes plc (NASDAQ: ALKS) announced today that its Chief Executive Officer, Richard Pops, will participate in a fireside chat at the Goldman Sachs 38th Annual Global Healthcare Conference on Thursday, June 15, 2017 at 8:40 a.m. PT (11:40 a.m. ET/4:40 p.m. BST) from Rancho Palos Verdes, Calif. The audio portion of the fireside chat may be accessed under the Investors tab on and will be archived for 14 days.

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’ website at

Source: Alkermes plc

Alkermes plc
Jennifer Zibuda, +1 781-609-6129
Corporate Communications